GeoVax Labs (GOVXW) News Today $0.04 +0.00 (+0.46%) As of 05/20/2025 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock GOVXW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period GeoVax Reaffirms Urgent Need for Multi-Antigen COVID-19 Vaccines as CDC Shifts RecommendationsMay 20 at 1:00 PM | finance.yahoo.comGeoVax Expands Gedeptin(R) Patent PortfolioMay 7, 2025 | finance.yahoo.comGeoVax Labs Earnings Call: Mixed Sentiment and Future ProspectsMay 2, 2025 | tipranks.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2025 Earnings Call TranscriptMay 2, 2025 | insidermonkey.comGeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual MeetingApril 29, 2025 | finance.yahoo.comRoth says BARDA stopping funding for GeoVax COVID trial similar to peersApril 17, 2025 | markets.businessinsider.comEQS-News: GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business MomentumApril 16, 2025 | markets.businessinsider.comGeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business MomentumApril 16, 2025 | finance.yahoo.comGeoVax Labs price target lowered to $8.50 from $15 at Alliance Global PartnersApril 15, 2025 | markets.businessinsider.comGeoVax to Present Clinical Data at Upcoming April Industry EventsApril 15, 2025 | finance.yahoo.comEQS-News: GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine PatentApril 10, 2025 | markets.businessinsider.comAlliance Global Partners Keeps Their Buy Rating on GeoVax Labs (GOVX)March 30, 2025 | markets.businessinsider.comNoble Financial Sticks to Its Buy Rating for GeoVax Labs (GOVX)March 30, 2025 | markets.businessinsider.comGeoVax to Present at the 37th Annual Roth ConferenceMarch 12, 2025 | finance.yahoo.comGeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense StrategyMarch 3, 2025 | finance.yahoo.comEQS-News: GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense StrategyMarch 3, 2025 | markets.businessinsider.comGeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International ConcernFebruary 28, 2025 | finance.yahoo.comGeoVax has ‘timely and critical’ Mpox solution, says D. Boral CapitalFebruary 28, 2025 | markets.businessinsider.comMpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply DiversificationFebruary 19, 2025 | finance.yahoo.comEQS-News: GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public HealthFebruary 18, 2025 | markets.businessinsider.comGeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public HealthFebruary 18, 2025 | finance.yahoo.comGeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor ConferenceFebruary 4, 2025 | finance.yahoo.comGeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate InitiativeFebruary 3, 2025 | finance.yahoo.comEQS-News: GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply WorldwideJanuary 27, 2025 | markets.businessinsider.comGeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply WorldwideJanuary 27, 2025 | finance.yahoo.comGeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 TrialJanuary 16, 2025 | finance.yahoo.comGeoVax Labs to initiate Phase 2 clinical study of gedeptinJanuary 16, 2025 | markets.businessinsider.comEQS-News: GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 TrialJanuary 15, 2025 | markets.businessinsider.comGeoVax adjourns Special Meeting due to low quorumDecember 20, 2024 | investing.comGOVXW GeoVax Labs, Inc. WT EXP 092925December 8, 2024 | seekingalpha.comGeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic LeukemiaNovember 19, 2024 | stockhouse.comNoble Financial Keeps Their Buy Rating on GeoVax Labs (GOVX)November 13, 2024 | markets.businessinsider.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comThis GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For MondayNovember 12, 2024 | benzinga.comRocket Pharmaceuticals, Inc. (9IP1.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comGeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The MoveSeptember 4, 2024 | insidermonkey.comGeoVax Labs, Inc. (GOVXW)August 21, 2024 | au.finance.yahoo.comStock Market Today: Dow ends lower, S&P 500 snaps 8-day winning streak as comeback rally pausesAugust 21, 2024 | marketwatch.comEmergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?August 15, 2024 | benzinga.comStrong Buy Rating for GeoVax Labs on Government Support and Promising Trial ProspectsAugust 9, 2024 | markets.businessinsider.comGeoVax Labs Inc.July 19, 2024 | barrons.comGeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024May 7, 2024 | finance.yahoo.comGeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineApril 4, 2024 | finance.yahoo.comGeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressMarch 28, 2024 | finance.yahoo.comGeoVax Announces Multiple Patent Issuances and AllowancesFebruary 13, 2024 | finance.yahoo.comGeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterFebruary 6, 2024 | finance.yahoo.comTrading was temporarily halted for "GOVXW" at 07:01 PM with a stated reason of "News pending."January 31, 2024 | marketbeat.comGeoVax, Inc.: GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementJanuary 29, 2024 | finanznachrichten.deEQS-News: GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementJanuary 29, 2024 | markets.businessinsider.comGeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementJanuary 29, 2024 | finance.yahoo.com Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVXW and its competitors with MarketBeat's FREE daily newsletter. Email Address GOVXW Media Mentions By Week GOVXW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOVXW News Sentiment▼0.400.65▲Average Medical News Sentiment GOVXW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOVXW Articles This Week▼10▲GOVXW Articles Average Week Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today Lexaria Bioscience News Today Neonc Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOVXW) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeoVax Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
